000			01386 a2200457 4500
005			20250512114950.0
264		0	_c19740827
008			197408s 0 0 eng d
022			_a0091-3332
040			_aNLM _beng _cNLM
100	1		_aKernis, M M
245	0	0	_aPrinciples of teratology. _h[electronic resource]
260			_bObstetrics and gynecology annual _c1972
300			_a1-28 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAbnormalities, Drug-Induced
650	0	4	_aAmniocentesis _xadverse effects
650	0	4	_aAnimals
650	0	4	_aChromosome Aberrations
650	0	4	_aChromosome Disorders
650	0	4	_aCongenital Abnormalities _xembryology
650	0	4	_aDrug Interactions
650	0	4	_aEmbryo Implantation
650	0	4	_aEmbryonic and Fetal Development
650	0	4	_aFemale
650	0	4	_aGestational Age
650	0	4	_aHumans
650	0	4	_aInfant, Newborn
650	0	4	_aLethal Dose 50
650	0	4	_aMaternal Age
650	0	4	_aMaternal-Fetal Exchange
650	0	4	_aMetabolism, Inborn Errors _xembryology
650	0	4	_aMorphogenesis
650	0	4	_aMosaicism
650	0	4	_aPregnancy
650	0	4	_aThalidomide _xadverse effects
650	0	4	_aTrisomy
650	0	4	_aTrypan Blue _xadverse effects
650	0	4	_aUnited States
773	0		_tObstetrics and gynecology annual _gvol. 1 _gno. 0 _gp. 1-28
999			_c4604138 _d4604138